1. Home
  2. AQST vs AEVA Comparison

AQST vs AEVA Comparison

Compare AQST & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • AEVA
  • Stock Information
  • Founded
  • AQST 2004
  • AEVA 2019
  • Country
  • AQST United States
  • AEVA United States
  • Employees
  • AQST N/A
  • AEVA N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • AEVA Auto Parts:O.E.M.
  • Sector
  • AQST Health Care
  • AEVA Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • AEVA Nasdaq
  • Market Cap
  • AQST 809.3M
  • AEVA 964.6M
  • IPO Year
  • AQST 2018
  • AEVA N/A
  • Fundamental
  • Price
  • AQST $5.59
  • AEVA $11.86
  • Analyst Decision
  • AQST Strong Buy
  • AEVA Strong Buy
  • Analyst Count
  • AQST 7
  • AEVA 4
  • Target Price
  • AQST $10.00
  • AEVA $24.50
  • AVG Volume (30 Days)
  • AQST 3.0M
  • AEVA 2.1M
  • Earning Date
  • AQST 11-05-2025
  • AEVA 11-05-2025
  • Dividend Yield
  • AQST N/A
  • AEVA N/A
  • EPS Growth
  • AQST N/A
  • AEVA N/A
  • EPS
  • AQST N/A
  • AEVA N/A
  • Revenue
  • AQST $43,397,000.00
  • AEVA $15,154,000.00
  • Revenue This Year
  • AQST N/A
  • AEVA $107.53
  • Revenue Next Year
  • AQST $51.39
  • AEVA $104.37
  • P/E Ratio
  • AQST N/A
  • AEVA N/A
  • Revenue Growth
  • AQST N/A
  • AEVA 89.90
  • 52 Week Low
  • AQST $2.12
  • AEVA $2.52
  • 52 Week High
  • AQST $7.55
  • AEVA $38.80
  • Technical
  • Relative Strength Index (RSI)
  • AQST 37.83
  • AEVA 33.73
  • Support Level
  • AQST $5.44
  • AEVA $11.51
  • Resistance Level
  • AQST $6.85
  • AEVA $14.11
  • Average True Range (ATR)
  • AQST 0.42
  • AEVA 1.30
  • MACD
  • AQST -0.20
  • AEVA -0.46
  • Stochastic Oscillator
  • AQST 7.47
  • AEVA 4.58

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.

Share on Social Networks: